70
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Effect of inhaled drugs on anxiety and depression in patients with chronic obstructive pulmonary disease: a prospective observational study

, , , &
Pages 747-754 | Published online: 11 Apr 2016

References

  • Global Strategy for the Diagnosis MaPoCGlobal Initiative for Chronic Obstructive Lung Disease (GOLD)2015 Available from: http://www.goldcopd.org/Accessed February 12, 2016
  • CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
  • CelliBRThomasNEAndersonJAEffect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH studyAm J Respir Crit Care Med2008178433233818511702
  • TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
  • SuissaSKezouhAErnstPInhaled corticosteroids and the risks of diabetes onset and progressionAm J Med2010123111001100620870201
  • RichyFBousquetJEhrlichGEInhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic reviewOsteoporos Int200314317919012730758
  • WeatherallMJamesKClayJDose–response relationship for risk of non-vertebral fracture with inhaled corticosteroidsClin Exp Allergy20083891451145818537983
  • WeatherallMWijesingheMPerrinKHarwoodMBeasleyRMeta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapyThorax2010651394320029037
  • SinghSLokeYKFurbergCDInhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysisJAMA2008300121439145018812535
  • NakaTIdeSNakakoTActivation of beta-adrenoceptors in the bed nucleus of the stria terminalis induces food intake reduction and anxiety-like behaviorsNeuropharmacology20136732633023219657
  • MineurYSObayemiAWigestrandMBCholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behaviorProc Natl Acad Sci U S A201311093573357823401542
  • DagyteGDen BoerJATrentaniAThe cholinergic system and depressionBehav Brain Res2011221257458220170685
  • DrevetsWCZarateCAJrFureyMLAntidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a reviewBiol Psychiatry201373121156116323200525
  • KennaHAPoonAWde los AngelesCPKoranLMPsychiatric complications of treatment with corticosteroids: review with case reportPsychiatry Clin Neurosci201165654956022003987
  • BrownESEffects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapyAnn N Y Acad Sci20091179415519906231
  • ZigmondASSnaithRPThe hospital anxiety and depression scaleActa Psychiatr Scand19836763613706880820
  • ChoiSKMinSJChoMSJoungHParkSMAnxiety and depression among North Korean young defectors in South Korea and their association with health-related quality of lifeYonsei Med J201152350250921488195
  • KangHJStewartRKimJMComparative validity of depression assessment scales for screening poststroke depressionJ Affect Disord20131471–318619123167974
  • JangJEKimSWKimSYReligiosity, depression, and quality of life in Korean patients with breast cancer: a 1-year prospective longitudinal studyPsychooncology201322492292922544445
  • Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease2014 Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.htmlAccessed March 18, 2016
  • SnaithRPThe hospital anxiety and depression scaleHealth Qual Life Outcomes200312912914662
  • RichmondMSegerDCentral anticholinergic syndrome in a child: a case reportJ Emerg Med1985364534563837045
  • FrielleTDanielKWCaronMGLefkowitzRJStructural basis of beta-adrenergic receptor subtype specificity studied with chimeric beta 1/beta 2-adrenergic receptorsProc Natl Acad Sci U S A19888524949494982849109
  • GuptaPO’MahonyMSPotential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribingDrugs Aging200825541544318447405
  • JohnsonMThe β-adrenoceptorAm J Respir Crit Care Med19981585 Pt 3S146S1539817738
  • van VlymenJMParlowJLThe effects of reversal of neuromuscular blockade on autonomic control in the perioperative periodAnesth Analg19978411481548989016
  • SinghSLokeYKEnrightPFurbergCDPro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medicationsThorax201368111411622764216
  • GiftAGWoodRMCahillCADepression, somatization and steroid use in chronic obstructive pulmonary diseaseInt J Nurs Stud19892632812862767912
  • MaurerJRebbapragadaVBorsonSAnxiety and depression in COPD: current understanding, unanswered questions, and research needsChest20081344 Suppl43S56S18842932
  • PostolachePCostinMDumbravaELCojocaruDCAnxiety and depression in patients with chronic obstructive pulmonary disease: an open agenda for researchRev Med Chir Soc Med Nat Iasi20141181394424741773
  • XuWColletJPShapiroSIndependent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizationsAm J Respir Crit Care Med2008178991392018755925
  • NgTPNitiMTanWCCaoZOngKCEngPDepressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of lifeArch Intern Med20071671606717210879
  • TuranOYemezBItilOThe effects of anxiety and depression symptoms on treatment adherence in COPD patientsPrim Health Care Res Dev201415324425123561004
  • HarrisonSLGreeningNJWilliamsJEMorganMDSteinerMCSinghSJHave we underestimated the efficacy of pulmonary rehabilitation in improving mood?Respir Med2012106683884422197576
  • CoventryPADoes pulmonary rehabilitation reduce anxiety and depression in chronic obstructive pulmonary disease?Curr Opin Pulm Med200915214314919532030
  • Paz-DiazHMontes de OcaMLopezJMCelliBRPulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPDAm J Phys Med Rehabil2007861303617304686
  • PuhanMAFreyMBuchiSSchunemannHJThe minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary diseaseHealth Qual Life Outcomes200864618597689
  • HerediaJLTiotropium bromide: an updateOpen Respir Med J20093435219461900
  • ShefferALSilvermanMWoolcockAJDiazPVLindbergBLindmarkBLong-term safety of once-daily budesonide in patients with early-onset mild persistent asthma: results of the Inhaled Steroid Treatment as Regular Therapy in Early Asthma (START) studyAnn Allergy Asthma Immunol2005941485415702816
  • KestenSCelliBDecramerMLeimerITashkinDTiotropium HandiHaler in the treatment of COPD: a safety reviewInt J Chron Obstruct Pulmon Dis2009439740920037679
  • NICEDepression: Evidence Update April 2012National Institute for Health and Clinical Excellence2012 Available from: http://www.nice.org.uk/guidance/cg90/evidenceAccessed February 12, 2016